Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum

Abstract

The retinal microvasculature and structure exhibit alterations in individuals with SCD. Macular ganglion cell complex thickness demonstrates correlations with cerebral perfusion. The retina holds potential as a novel biomarker for early detection of AD.